These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 10789490)

  • 21. Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI Chemoprevention Drug Development Program.
    Steele VE; Moon RC; Lubet RA; Grubbs CJ; Reddy BS; Wargovich M; McCormick DL; Pereira MA; Crowell JA; Bagheri D
    J Cell Biochem Suppl; 1994; 20():32-54. PubMed ID: 7616752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoprevention of colorectal cancer: ready for routine use?
    Arber N; Levin B
    Curr Top Med Chem; 2005; 5(5):517-25. PubMed ID: 15974946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current and future clinical strategies in colon cancer prevention and the emerging role of chemoprevention.
    Boursi B; Arber N
    Curr Pharm Des; 2007; 13(22):2274-82. PubMed ID: 17692000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical in vitro models from genetically engineered mice for breast and colon cancer (Review).
    Telang N; Katdare M
    Oncol Rep; 2011 May; 25(5):1195-201. PubMed ID: 21399881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials.
    Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet R; Sigman CC
    Cancer Res; 1994 Apr; 54(7 Suppl):2015s-2024s. PubMed ID: 8137331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoprevention of colon cancer: current status and future prospects.
    Gustin DM; Brenner DE
    Cancer Metastasis Rev; 2002; 21(3-4):323-48. PubMed ID: 12549770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New agents for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Steele VE; Lubet RA; Doody LA; Malone WF; Hawk ET; Sigman CC
    J Cell Biochem Suppl; 1996; 26():1-28. PubMed ID: 9154166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic and epigenetic cancer chemoprevention on molecular targets during multistage carcinogenesis.
    Kim HS; Kacew S; Lee BM
    Arch Toxicol; 2016 Oct; 90(10):2389-404. PubMed ID: 27538406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surrogate endpoint biomarkers for phase II cancer chemoprevention trials.
    Kelloff GJ; Boone CW; Crowell JA; Steele VE; Lubet R; Doody LA
    J Cell Biochem Suppl; 1994; 19():1-9. PubMed ID: 7823579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemoprevention trials and surrogate end point biomarkers in the cervix.
    Mitchell MF; Hittelman WK; Lotan R; Nishioka K; Tortolero-Luna G; Richards-Kortum R; Wharton JT; Hong WK
    Cancer; 1995 Nov; 76(10 Suppl):1956-77. PubMed ID: 8634987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of chemopreventive agents for lung and upper aerodigestive tract cancers.
    Kelloff GJ; Boone CW; Steele VK; Perloff M; Crowell J; Doody LA
    J Cell Biochem Suppl; 1993; 17F():2-17. PubMed ID: 8412195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of cancer preventive agents from natural products: from plants to prevention.
    Mehta RG; Pezzuto JM
    Curr Oncol Rep; 2002 Nov; 4(6):478-86. PubMed ID: 12354359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoprevention of prostate cancer by diet-derived antioxidant agents and hormonal manipulation (Review).
    Pathak SK; Sharma RA; Mellon JK
    Int J Oncol; 2003 Jan; 22(1):5-13. PubMed ID: 12469179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemoprevention of prostate cancer: current status and future directions.
    Lieberman R
    Cancer Metastasis Rev; 2002; 21(3-4):297-309. PubMed ID: 12549768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermediate biomarkers of precancer and their application in chemoprevention.
    Kelloff GJ; Malone WF; Boone CW; Steele VE; Doody LA
    J Cell Biochem Suppl; 1992; 16G():15-21. PubMed ID: 1469895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surrogate end-point biomarkers in chemopreventive drug development.
    Kelloff GJ; Sigman CC; Hawk ET; Johnson KM; Crowell JA; Guyton KZ
    IARC Sci Publ; 2001; 154():13-26. PubMed ID: 11220652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detoxication enzymes and chemoprevention.
    Wilkinson J; Clapper ML
    Proc Soc Exp Biol Med; 1997 Nov; 216(2):192-200. PubMed ID: 9349688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronicles in drug discovery.
    Moral MA; Khurdayan VK; Bozzo J
    Drug News Perspect; 2006 Oct; 19(8):485-9. PubMed ID: 17160149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Terpenoids and breast cancer chemoprevention.
    Rabi T; Bishayee A
    Breast Cancer Res Treat; 2009 May; 115(2):223-39. PubMed ID: 18636327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospects for chemoprevention of cancer.
    Tamimi RM; Lagiou P; Adami HO; Trichopoulos D
    J Intern Med; 2002 Apr; 251(4):286-300. PubMed ID: 11952879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.